Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128654) titled 'A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers' on Aug. 14.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Celltrion

Condition: Healthy

Intervention: Drug: CTL02 Drug: CTL0201

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: August 2025

Target Sample Size: 40

Countries of Recruitment: Korea, Republic of

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07128654

Published by HT Di...